Arden Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Arden Shen has a total of 233 co-authors. Here are the top co-authors by number of shared publications:
- Anastasia J. Whitson
Department of Orthopaedic Surgery and Sports Medicine, University of Washington, Seattle, USA
5 shared publications Grant E. Garrigues
5 shared publications- Gregory P. Nicholson
Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, USA
5 shared publications - Jason Edward Hsu
Department of Orthopaedic Surgery and Sports Medicine, University of Washington, Seattle, USA
5 shared publications - Michael Khazzam
Baylor Scott & White Orthopaedic Associates of Dallas Complex Shoulder Institute, 1631 Lancaster Drive #230, Grapevine, Texas, 76051
5 shared publications - Thomas W. Wright
Department of Orthopaedic Surgery and Sports Medicine, University of Florida, Gainesville, FL, USA
5 shared publications
Latest Publications
- Open Access
- 27 May 2026
- Published by Elsevier in Journal of Shoulder and Elbow Arthroplasty
- Vol. 10  (3)
Outpatient revision shoulder arthroplasty can Be safe and effective: a matched analysis
- 27 May 2026
- Published by Elsevier in Journal of Shoulder and Elbow Arthroplasty
- Vol. 10  (3)
Open AccessOutpatient revision shoulder arthroplasty can Be safe and effective: a matched analysis
- 14 May 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35  (10) , 2362-2371
Evaluation of the International Consensus Meeting (ICM) Diagnostic Categories for Shoulder Periprosthetic Joint Infection: C. Acnes Predominates even in Definite Infections
- 14 May 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35  (10) , 2362-2371
Evaluation of the International Consensus Meeting (ICM) Diagnostic Categories for Shoulder Periprosthetic Joint Infection: C. Acnes Predominates even in Definite Infections
- 30 April 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35  (10) , 2372-2381
Can standard preoperative serum laboratory tests predict bacterial presence at the time of revision shoulder arthroplasty?
- 30 April 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35  (10) , 2372-2381
Can standard preoperative serum laboratory tests predict bacterial presence at the time of revision shoulder arthroplasty?
- 11 April 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35  (10) , e947-e957
Return to golf after shoulder arthroplasty: an American Shoulder and Elbow Surgeons multicenter study predicting performance after reverse total shoulder arthroplasty and anatomic total shoulder arthroplasty
- 11 April 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35  (10) , e947-e957
Return to golf after shoulder arthroplasty: an American Shoulder and Elbow Surgeons multicenter study predicting performance after reverse total shoulder arthroplasty and anatomic total shoulder arthroplasty
- 27 February 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35  (7) , 1667-1676
Return to weightlifting after shoulder arthroplasty: an ASES multicenter study predicting performance after reverse shoulder arthroplasty and anatomic shoulder arthroplasty
- 27 February 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35  (7) , 1667-1676
Return to weightlifting after shoulder arthroplasty: an ASES multicenter study predicting performance after reverse shoulder arthroplasty and anatomic shoulder arthroplasty
- 6 December 2025
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35  (6) , e654-e663
Reverse total shoulder arthroplasty with the Tornier Perform implant with lower trapezius transfer for symptomatic rotator cuff deficiency with external rotation lag and Hornblower's sign
- 6 December 2025
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35  (6) , e654-e663
Reverse total shoulder arthroplasty with the Tornier Perform implant with lower trapezius transfer for symptomatic rotator cuff deficiency with external rotation lag and Hornblower's sign
- 9 October 2025
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35  (4) , 965-977
Surgical and patient factors associated with baseplate failures after reverse shoulder arthroplasty: a study by the ASES Complications of RSA Multicenter Research Group
- 9 October 2025
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35  (4) , 965-977
Surgical and patient factors associated with baseplate failures after reverse shoulder arthroplasty: a study by the ASES Complications of RSA Multicenter Research Group
- Open Access
- 23 May 2025
- Published by Elsevier in JSES International
- Vol. 9  (5) , 1616-1622
Pre-operative Insurance Mandated Physical Therapy does not Prevent the Need for Shoulder Arthroplasty in Patients with Glenohumeral Osteoarthritis
- 23 May 2025
- Published by Elsevier in JSES International
- Vol. 9  (5) , 1616-1622
Open AccessPre-operative Insurance Mandated Physical Therapy does not Prevent the Need for Shoulder Arthroplasty in Patients with Glenohumeral Osteoarthritis
- 7 December 2023
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 21  (1) , 11-21
Sex Differences in Circulating Biomarkers of Heart Failure
Purpose of RevSiew Evidence is scaling up for sex differences in heart failure; however, clinical relevance of sex-specific differential thresholds for biomarkers is not clearly known. Current ambiguity warrants a further look into the sex-specific studies on cardiac biomarkers and may facilitate understanding of phenotypic presentations, clinical manifestations, and pathophysiologic pathway differences in men and women. Recent Findings Recent studies have confirmed the fact that females have differential threshold for biomarkers, with lower troponin and higher NT proBNP levels. Ambiguity continues to exist in the clinical relevance of ST-2, Galectin 3, and other biomarkers. Novel biomarkers, proteomic biomarkers, and circulating micro RNAs with machine learning are actively being explored. Biomarkers in HFpEF patients with higher female representation are evolving. In recent clinical trials, sex-related difference in biomarkers is not seen despite therapeutic intervention being more effective in females compared to males. Summary Sex-related difference exists in the expression of biomarkers in health and in various disease states of heart failure. However, this differentiation has not effectively translated into the clinical practice in terms of diagnostic studies or prognostication. Active exploration to bridge the knowledge gap and novel technologies can shed more light in this area.
- 7 December 2023
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 21  (1) , 11-21
Sex Differences in Circulating Biomarkers of Heart Failure
Purpose of RevSiew Evidence is scaling up for sex differences in heart failure; however, clinical relevance of sex-specific differential thresholds for biomarkers is not clearly known. Current ambiguity warrants a further look into the sex-specific studies on cardiac biomarkers and may facilitate understanding of phenotypic presentations, clinical manifestations, and pathophysiologic pathway differences in men and women. Recent Findings Recent studies have confirmed the fact that females have differential threshold for biomarkers, with lower troponin and higher NT proBNP levels. Ambiguity continues to exist in the clinical relevance of ST-2, Galectin 3, and other biomarkers. Novel biomarkers, proteomic biomarkers, and circulating micro RNAs with machine learning are actively being explored. Biomarkers in HFpEF patients with higher female representation are evolving. In recent clinical trials, sex-related difference in biomarkers is not seen despite therapeutic intervention being more effective in females compared to males. Summary Sex-related difference exists in the expression of biomarkers in health and in various disease states of heart failure. However, this differentiation has not effectively translated into the clinical practice in terms of diagnostic studies or prognostication. Active exploration to bridge the knowledge gap and novel technologies can shed more light in this area.